Efficacy, safety, and pharmacokinetics of intravenous midazolam in Japanese children with status epilepticus
- 1 January 2019
- journal article
- research article
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 396, 150-158
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- The drug treatment of status epilepticus in Europe: Consensus document from a workshop at the first London Colloquium on Status EpilepticusEpilepsia, 2008
- Efficacy of Intravenous Midazolam for Status Epilepticus in ChildhoodPediatric Neurology, 2007
- Status Epilepticus: Clinical Analysis of a Treatment Protocol Based on Midazolam and PhenytoinJournal of Child Neurology, 2005
- Efficacy of Intravenous Treatment of Midazolam in Children with Status EpilepticusJournal of the Japan Epilepsy Society, 2005
- Continuous infusion of midazolam in the treatment of refractory generalized convulsive status epilepticusNeurological Sciences, 2002
- Cytochrome P450 3AClinical Pharmacokinetics, 1999
- Clinical Pharmacology of Midazolam in Infants and ChildrenClinical Pharmacokinetics, 1998
- Intravenous midazolam for the treatment of refractory status epilepticusCritical Care Medicine, 1992
- Midazolam: an effective intravenous agent for seizure control.Archives of Emergency Medicine, 1987
- Clinical, Electroencephalographic, and Pharmacokinetic Studies of a Water-soluble Benzodiazepine, Midazolam MaleateAnesthesiology, 1979